Find your next paid study

Memorial Sloan Kettering Cancer CenterNCT04891289

~$75 – $2,000

Actual pay is set by the research site.

Efficacy of Intravenous Oxytocin to Speed Recovery After Total Hip Arthroplasty

The purpose of this study is to test whether perioperative intravenous (IV) oxytocin compared to placebo results in faster recovery in disability as measured b…

Total Hip Arthroplasty

Wake Forest University Health SciencesNCT07430228

~$75 – $2,000

Actual pay is set by the research site.

Traumatic Brain InjuriesTBI (Traumatic Brain Injury)MTBI - Mild Traumatic Brain Injury+4 more

Rehabilitation Through Virtual Immersion & Integrated Exposure for Mild Traumatic Brain Injury (ReVIVE for mTBI)

The primary goal of this study is to evaluate the effectiveness of an integrated therapeutic model - combining VR and standard psychotherapy in improving execu…

Johns Hopkins UniversityNCT07890337

~$150 – $3,000

Actual pay is set by the research site.

Metastatic Castration-resistant Prostate Cancer

Chemical-Shift-Encoded MRI for Active Bone Marrow Dosimetry in Radiopharmaceutical Therapy

This study compares two different imaging procedures to each other, one using positron emission tomography (PET) with fluorothymidine F-18 (FLT) (FLT PET for s…

University of Wisconsin, MadisonNCT07609225

~$150 – $3,000

Actual pay is set by the research site.

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia (Stride Dystonia)

Stride Dystonia is a randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety, and tolerability of VIM0423 in individuals with isola…

Dystonia

Vima TherapeuticsNCT07304089

~$75 – $2,800

Actual pay is set by the research site.

A 12-Week, Phase 2, Multicenter, Randomized, Double-Masked, Vehicle Controlled, Parallel Group Study With 2 Weeks of Follow-Up to Evaluate the Efficacy and Safety of DFL24498 0.08% Topical Ophthalmic Solution Versus Vehicle in Participants With Dry Eye Disease

This is a Phase 2, randomized, multicenter, double masked, vehicle controlled, parallel group study to evaluate the efficacy and safety of DFL24498 topical oph…

Dry Eye Disease (DED)

Dompé Farmaceutici S.p.ANCT07503886

~$75 – $3,000

Actual pay is set by the research site.

Metastatic Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8Stage IV Renal Cell Cancer AJCC v8+1 more

Randomized Phase II Stereotactic Ablative Radiation Therapy (SABR) for Metastatic Unresected Renal Cell Carcinoma (RCC) Receiving Immunotherapy (SAMURAI)

This phase II trial tests whether the addition of radiation to the primary tumor, typically given with stereotactic ablative radiation therapy (SABR), in combi…

~$75 – $3,000

Actual pay is set by the research site.

NRG OncologyNCT05327686

Screening Evaluation of Volunteers for Studies of Pain

This study is a screening evaluation for volunteers who are interested in participating in National Center for Complementary and Integrative Health (NCCIH) res…

Pain

National Center for Complementary and Integrative Health (NCCIH)NCT07712874

~$10 – $1,125

Actual pay is set by the research site.

Phase 3

A Phase 3 Randomized, Open-Label Study of Atebimetinib in Combination With the Modified Gemcitabine and Nab-Paclitaxel Regimen Versus the Standard Gemcitabine and Nab-Paclitaxel Regimen for the Treatment of Patients With Metastatic Pancreatic Ductal Pancreatic Adenocarcinoma Cancer (MAPKeeper 301)

The purpose of this study is to evaluate the safety and efficacy of atebimetinib in combination with modified GnP compared with SOC GnP alone.

Pancreatic CancerPancreatic Cancer MetastaticPDAC+5 more

Immuneering CorporationNCT07562152

~$50 – $2,100

Actual pay is set by the research site.

Functional, Clinical, and Performance Outcomes Following Pelvic and Acetabular Fracture: A Prospective Observational Study

The purpose of this study is to understand the trajectory of function and self-reported outcomes of patients following pelvic and acetabular, treated both oper…

Pelvic FractureAcetabular FracturePubic Rami Fracture

Wake Forest University Health SciencesNCT04615104

~$10 – $750

Actual pay is set by the research site.

Chronic Weight Management

A Phase I, Randomized, Placebo-controlled, Double-blind, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Two Formulations of ASC36 Injection for Subcutaneous Use in Adult Participants With Obesity or Are Overweight

This randomized, double-blind, placebo-controlled single ascending dose (SAD)/ multiple ascending dose (MAD) study is designed to evaluate the safety, tolerabi…

Ascletis Pharma (China) Co., LimitedNCT07893093

~$150 – $4,200

Actual pay is set by the research site.

Advanced Pancreatic Ductal AdenocarcinomaMetastatic Pancreatic Ductal AdenocarcinomaStage III Pancreatic Cancer AJCC v8+2 more

Phase I/II Study of the MEK Inhibitor Selumetinib Plus DS-8201a (Trastuzumab Deruxtecan) in KRAS-Mutant, HER2-Expressing Pancreatic Ductal Adenocarcinoma

This phase I/II trial tests the safety, side effects, best dose and how well giving selumetinib with trastuzumab deruxtecan (DS-8201a) works for the treatment …